Abstract:Brain aging is characterized by a decrease in N‐methyl D‐aspartate mediated glutamate‐stimulated release of norepinephrine in the cerebral cortex. Proposed target sites for pharmacological restoration of deficits in norepinephrine release in the aging brain include blockade of alpha‐2 adrenergic receptors using mirtazapine or idazoxan, and targeting the norepinephrine reuptake inhibitor with the CNS stimulant methylphenidate. Aging affects virtually all organs of the body, but perhaps it has the most profound effects on the brain and its neurotransmitter systems, which influence a wide range of crucial functions, such as attention, focus, mood, neuroendocrine and autonomic functions, and sleep cycles. All of these essential functions, as well as fundamental cognitive processes such as memory, recall, and processing speed, utilize neuronal circuits that depend on neurotransmitter signaling between neurons. Glutamate (Glu), the main excitatory neurotransmitter in the CNS, is involved in most neuronal excitatory functions, including release of the neurotransmitter norepinephrine (NE). Previous studies from our lab demonstrated that the age‐associated decline in Glu‐stimulated NE release in rat cerebral cortex and hippocampus mediated by NMDA glutamate receptors, as well as deficits in dendritic spines, and cognitive functions are fully rescued by the CNS stimulant amphetamine. Here we further investigated Glu‐stimulated NE release in the cerebral cortex to identify additional novel target sites for restoration of Glu‐stimulated NE release. We found that blockade of alpha‐2 adrenergic receptors fully restores Glu‐stimulated NE release to the levels of young controls. In addition, we investigated the density and responsiveness of NMDA receptors as a potential underlying neuronal mechanism that could account for the observed age‐associated decline in Glu‐stimulated NE release. In the basal state of the receptor (no added glutamate and glycine) the density of NMDA receptors in the cortex from young and aged rats was similar. However, in contrast, in the presence of 10 μM added glutamate, which opens the receptor channel and increases the number of available [3H]‐MK‐801 binding sites within the channel, the density of [3H]‐MK‐801 binding sites was significantly less in the cortex from aged rats.

Impaired maze performance in aged rats is accompanied by increased density of NMDA, 5-HT1A, and alpha-adrenoceptor binding in hippocampus

Long-Term Potentiation is Impaired in Middle-Aged Rats: Regional Specificity and Reversal by Adenosine Receptor Antagonists

Age-related changes in glutamate release in the CA3 and dentate gyrus of the rat hippocampus

Hippocampal NMDA receptors and the previous experience effect on memory

Hilar interneuron vulnerability distinguishes aged rats with memory impairment

The impairment of the hippocampal neuro-vascular unit precedes changes in spatial cognition in naturally aged rats

Pharmacological target sites for restoration of age‐associated deficits in NMDA receptor‐mediated norepinephrine release in brain

Hippocampal Gαq/11 but not Gαo-coupled receptors are altered in aging

Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias.

Doublecortin and IGF-1R protein levels are reduced in spite of unchanged DNA methylation in the hippocampus of aged rats

Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model

Aging Patterns of Neuronal Nitric Oxide Synthase in Hippocampus of Senescence Accelerated Mouse

Positive modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors differentially alters spatial learning and memory in juvenile rats younger and older than three weeks

The Role of N-Methyl-D-Aspartate Receptor in Alzheimer'S Disease

Delay-dependent Impairment of Spatial Working Memory with Inhibition of NR2B-containing NMDA Receptors in Hippocampal CA1 Region of Rats

Role of GLR-1 in Age-Dependent Short-Term Memory Decline

Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease

Disordered Hippocampal Reactivations Predict Spatial Memory Deficits in a Mouse Model of Alzheimer's Disease

Influence of Dopamine D3 Receptor Knockout on Age-Related Decline of Spatial Memory

Retrieval of Consolidated Spatial Memory in the Water Maze Is Correlated with Expression of pCREB and Egr1 in the Hippocampus of Aged Mice.